{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T04:10:07Z","timestamp":1755922207420,"version":"3.44.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90777","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:39:27Z","timestamp":1755920367000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Outcomes and Influencing Factors in COVID-Associated Rhino-Orbital-Cerebral Mucormycosis: Globe Salvage Versus Exenteration"],"prefix":"10.7759","author":[{"given":"Vidhya","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samendra","family":"Karkhur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5202","article-title":"Rhino-orbital-cerebral mucormycosis-another deadly complication of COVID-19 infection","volume":"140","author":"Tooley AA","year":"2022","unstructured":"Tooley AA, Bradley EA, Woog JJ. Rhino-orbital-cerebral mucormycosis-another deadly complication of COVID-19 infection. JAMA Ophthalmol. 2022, 140:73-4. 10.1001\/jamaophthalmol.2021.5202","journal-title":"JAMA Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti K","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021, 44:2645-55. 10.2337\/dc21-1318","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108118","article-title":"Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed","volume":"162","author":"Wang A","year":"2020","unstructured":"Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020, 162:108118. 10.1016\/j.diabres.2020.108118","journal-title":"Diabetes Res Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis MS","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003, 362:1828-38. 10.1016\/S0140-6736(03)14904-5","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060652","article-title":"Gender specific differences in disease susceptibility: the role of epigenetics","volume":"9","author":"Migliore L","year":"2021","unstructured":"Migliore L, Nicol\u00ec V, Stoccoro A. Gender specific differences in disease susceptibility: the role of epigenetics. Biomedicines. 2021, 9:652. 10.3390\/biomedicines9060652","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"Revannavar SM","year":"2021","unstructured":"Revannavar SM, P S S, Samaga L, V K V. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-241663","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal R","year":"2021","unstructured":"Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, Kumar A. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021, 64:1452-9. 10.1111\/myc.13338","journal-title":"Mycoses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature","volume":"186","author":"Garg D","year":"2021","unstructured":"Garg D, Muthu V, Sehgal IS, et al.. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021, 186:289-98. 10.1007\/s11046-021-00528-2","journal-title":"Mycopathologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai RA","year":"1994","unstructured":"Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994, 39:3-22. 10.1016\/s0039-6257(05)80041-4","journal-title":"Surv Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:523. 10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel F","year":"2021","unstructured":"Pakdel F, Ahmadikia K, Salehi M, et al.. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran. Mycoses. 2021, 64:1238-52. 10.1111\/myc.13334","journal-title":"Mycoses"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.447","article-title":"The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research","volume":"3","author":"Marra AR","year":"2023","unstructured":"Marra AR, Kobayashi T, Callado GY, et al.. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023, 3:e168. 10.1017\/ash.2023.447","journal-title":"Antimicrob Steward Healthc Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399955-comparative-analysis-of-outcomes-and-influencing-factors-in-covid-associated-rhino-orbital-cerebral-mucormycosis-globe-salvage-versus-exenteration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:39:27Z","timestamp":1755920367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399955-comparative-analysis-of-outcomes-and-influencing-factors-in-covid-associated-rhino-orbital-cerebral-mucormycosis-globe-salvage-versus-exenteration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.90777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}